Osaic Holdings’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $700K | Buy |
30,203
+19,244
| +176% | +$446K | ﹤0.01% | 2506 |
|
|
2025
Q1 | $266K | Sell |
10,959
-3,711
| -25% | -$90K | ﹤0.01% | 3408 |
|
|
2024
Q4 | $306K | Sell |
14,670
-4,764
| -25% | -$99.4K | ﹤0.01% | 3212 |
|
|
2024
Q3 | $386K | Sell |
19,434
-3,901
| -17% | -$77.5K | ﹤0.01% | 3104 |
|
|
2024
Q2 | $361K | Sell |
23,335
-2,726
| -10% | -$42.2K | ﹤0.01% | 3045 |
|
|
2024
Q1 | $415K | Sell |
26,061
-28,318
| -52% | -$451K | ﹤0.01% | 3083 |
|
|
2023
Q4 | $914K | Sell |
54,379
-14,619
| -21% | -$246K | ﹤0.01% | 2603 |
|
|
2023
Q3 | $807K | Buy |
68,998
+33,086
| +92% | +$387K | ﹤0.01% | 2831 |
|
|
2023
Q2 | $483K | Sell |
35,912
-10,867
| -23% | -$146K | ﹤0.01% | 3181 |
|
|
2023
Q1 | $776K | Buy |
46,779
+15,737
| +51% | +$261K | ﹤0.01% | 2718 |
|
|
2022
Q4 | $577K | Buy |
31,042
+7,456
| +32% | +$139K | ﹤0.01% | 2895 |
|
|
2022
Q3 | $302K | Buy |
23,586
+21,882
| +1,284% | +$280K | ﹤0.01% | 3377 |
|
|
2022
Q2 | $12K | Buy |
1,704
+507
| +42% | +$3.57K | ﹤0.01% | 5930 |
|
|
2022
Q1 | $10K | Buy |
1,197
+29
| +2% | +$242 | ﹤0.01% | 6078 |
|
|
2021
Q4 | $8K | Sell |
1,168
-94
| -7% | -$644 | ﹤0.01% | 6323 |
|
|
2021
Q3 | $7K | Buy |
1,262
+152
| +14% | +$843 | ﹤0.01% | 6354 |
|
|
2021
Q2 | $6K | Buy |
1,110
+191
| +21% | +$1.03K | ﹤0.01% | 6250 |
|
|
2021
Q1 | $4K | Buy |
919
+719
| +360% | +$3.13K | ﹤0.01% | 6190 |
|
|
2020
Q4 | $1K | Sell |
200
-1,900
| -90% | -$9.5K | ﹤0.01% | 6092 |
|
|
2020
Q3 | $7K | Buy |
2,100
+1,400
| +200% | +$4.67K | ﹤0.01% | 5395 |
|
|
2020
Q2 | $3K | Sell |
700
-300
| -30% | -$1.29K | ﹤0.01% | 5576 |
|
|
2020
Q1 | $4K | Buy |
+1,000
| New | +$4K | ﹤0.01% | 5358 |
|